VENMIX 20 MG FILM COATED TABLET (28 TABLETS) – What is it, Uses & 2026 Price in Turkey

by

Clinical Data Review: Comprehensive profile for VENMIX 20 MG FILM COATED TABLET (28 TABLETS), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: VENMIX 20 MG FILM COATED TABLET (28 TABLETS)

Manufacturer: SANTA FARMA PHARMACEUTICALS INDUSTRY INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

RIVAROKSABAN 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

VENMIX 20 MG FILM COATED TABLET (28 TABLETS) is formulated with RIVAROKSABAN, a clinically established agent in medical practice.

  • Mechanism of Action: RIVAROKSABAN acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to RIVAROKSABAN therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name VENMIX 20 MG FILM COATED TABLET (28 TABLETS)
Barcode (GTIN) 8699527091114
Generic Name RIVAROKSABAN
License Holder SANTA FARMA PHARMACEUTICALS INDUSTRY INC.
Pharmacy Retail Price 990.22 TL
⚠️ Clinical Safety Warning

Do not administer VENMIX 20 MG FILM COATED TABLET (28 TABLETS) if the patient has a known hypersensitivity or allergy to RIVAROKSABAN. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via SANTA FARMA PHARMACEUTICALS INDUSTRY INC..

Leave a Comment